Targeted therapies for non-HPV-related head and neck cancer: challenges and opportunities in the context of predictive, preventive, and personalized medicine-Reference-Cited by-同舟云学术

Targeted therapies for non-HPV-related head and neck cancer: challenges and opportunities in the context of predictive, preventive, and personalized medicine

Published:2019-07-20 Issue:3 Volume:10 Page:291-305
ISSN:1878-5077
Container-title:EPMA Journal
language:en
Short-container-title:EPMA Journal

Author:

Shahoumi Linah A.,Yeudall W. Andrew^ORCID

Funder

National Institute of Dental and Craniofacial Research

Publisher

Springer Science and Business Media LLC

Subject

Biochemistry, medical,Health Policy,Drug Discovery

Link

http://link.springer.com/content/pdf/10.1007/s13167-019-00177-y.pdf

Reference166 articles.

1. Vigneswaran N, Williams MD. Epidemiologic trends in head and neck cancer and aids in diagnosis. Oral Maxillofac Surg Clin North Am. 2014;26(2):123–41.

2. Price KA, Cohen EE. Current treatment options for metastatic head and neck cancer. Curr Treat Options Oncol. 2012;13(1):35–46.

3. Sacco AG, Cohen EE. Current treatment options for recurrent or metastatic head and neck squamous cell carcinoma. J Clin Oncol. 2015;33(29):3305–13.

4. Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem. 1979;48:193–216.

5. Rubin Grandis J, Zeng Q, Drenning SD. Epidermal growth factor receptor--mediated stat3 signaling blocks apoptosis in head and neck cancer. Laryngoscope. 2000;110(5 Pt 1):868–74.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single-cell integrated transcriptomics reveals the role of keratinocytes in head and neck squamous cell carcinoma;Journal of Applied Genetics;2024-02-29

2. Reconstructing the immunosenescence core pathway reveals global characteristics in pan-cancer;Cancer Immunology, Immunotherapy;2023-08-22

3. SOCS1 as a Biomarker Candidate for HPV Infection and Prognosis of Head and Neck Squamous Cell Carcinomas;Current Issues in Molecular Biology;2023-06-30

4. pH-responsive graphene oxide loaded with targeted peptide and anticancer drug for OSCC therapy;Frontiers in Oncology;2022-08-03

5. Head and neck cancer organoids as a promising tool for personalized cancer therapy: A literature review;Health Science Reports;2022-04